|
xxxxxIolaus is a jawbreaker of a man, with a silly center and friendly yet serious person at heart. With a 'flexible' moral compass, Iolaus is a righteous and stauch believer of what he thinks is right, even if other people might not agree. A bit of a strange person, all things considered, Iolaus does not conform to social norms of how normal conversations should go.
|
|
|
xxxxxMuch of Iolaus' history is easily found on the website of his employer, Mount Sinai Hospital. His educational history is intense; he graduated summae cum laude from Tufts University with a double-major in biochemistry and biomedical science, and a minor in ethics. His education then continued to a double-doctoral program at the Tufts Sackler School of Graduate Biomedical Sciences and the Tufts School of Medicine, where he respectively received Ph.D in medical genetics and biochemistry, and an MD, both with honors. He underwent his residency and fellowships both at Mount Sinai Hospital, and was hired straight off to work as a consulting specialist on complex cases and genetic diseases. After several years, though, he slowly took his career there part time, and built the groundwork for his own clinic, a primary care clinic for mutants based in New York City.
xxxxxIolaus sunk much of his next few years into the creation and maintenance of the Mendel Clinic. Going from nothing to the only mutant health clinic in the world, it was more than a full time job. Iolaus was intimately involved in the creation of the Avicennan and Galenin drugs for treating the Rising Sickness, alongside Rasheed, Regan, Lucien, Parley, et al -- work for which he won the Nobel Prize in Medicine.
xxxxxIolaus eventually became aware of Rasheed's involvement with the Prometheus project. During this same period, he had visions of a future -- a future where he had turned his talents into making a highly infectious disease that could suppress all mutants abilities. Iolaus covered up Rasheed's involvement with Prometheus, judging that his money and his talents were better put to use making up for the harm that he had caused, rather than being expelled from the clinic.
xxxxxThat decision cost Iolaus dearly. After it became public, many clinic staff and donors resigned, and Iolaus was forced into suspension by the Board of Directors. As more staff continued leaving, Iolaus resigned his position on the board and as the CEO of the clinic, in the hopes of stemming the hemorrhage of staff and funds.
xxxxxAfter drifting for a while, Iolaus moved out of New York, taking up a new position within the same organization that he had seen himself working at in the future: the Centers for Disease Control and Prevention. Under the auspices of the Division of High-Consequence Pathogens and Pathology inside the National Center for Emerging and Zoonotic Infectious Diseases, Iolaus was appointed as the chief of a new branch to research the Rising and the new risks to the world's health: the Specially Designed Vectors Branch.
|
|
